Detalhe da pesquisa
1.
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
Hematol Oncol
; 41(4): 743-752, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086447
2.
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Cancer
; 128(21): 3880-3887, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107670
3.
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Blood
; 135(7): 463-471, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841594
4.
Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia.
Mod Pathol
; 31(3): 429-441, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29192651
5.
A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy.
Int J Mol Sci
; 18(7)2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696354
6.
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.
Br J Haematol
; 171(1): 84-90, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115047
7.
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML).
Leuk Lymphoma
; : 1-8, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538632
8.
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome.
Blood Adv
; 2024 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640348
9.
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Blood Adv
; 7(13): 3117-3127, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724515
10.
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.
Lancet Haematol
; 10(1): e46-e58, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370742
11.
Emergent Radiotherapy for Leukemia-Induced Cranial Neuropathies Refractory to Intrathecal Therapy.
Cureus
; 13(5): e15212, 2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34178531
12.
Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies.
Clin Cancer Res
; 27(7): 1893-1903, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495312
13.
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.
Leukemia
; 35(12): 3542-3550, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172893
14.
The Hi's and Lo's of Cytarabine in Acute Myeloid Leukemia.
Clin Cancer Res
; 26(13): 3073-3076, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284317
15.
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
Cancers (Basel)
; 12(11)2020 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139625
16.
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.
Blood Adv
; 4(9): 1894-1905, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380538
17.
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Cancers (Basel)
; 12(1)2019 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888052
18.
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial.
Clin Cancer Res
; 25(16): 4898-4906, 2019 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061068
19.
Leveraging Hypomethylating Agents for Better MDS Therapy.
Curr Hematol Malig Rep
; 13(6): 507-515, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267380
20.
Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.
Leuk Res
; 64: 34-41, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175379